180 Third Avenue
Construction Begins on 180 CityPoint in Waltham
Construction is underway for a new life science facility in Waltham, Massachusetts, which will help meet the surge in demand for new space in the Boston metro area. Situated in the CityPoint District, 180 CityPoint was designed to attract emerging and leading companies in the life science and biotechnology sector. continues to invest in Waltham and Lexington, and this modern facility will deliver 330,000 rentable square feet of lab and office space, as well as a wellness center, basketball court, grab-and-go café, and shared meeting space to the market.
“Waltham and other Greater Boston cities have become a hotbed for life science and biotechnology companies. As the race for space heats up, 180 CityPoint is strategically located on Route 128 and is strongly positioned to attract emerging firms as well as top talent,” said Rob Nagi, Principal of VHB. “Our longstanding relationships with the City of Waltham was key to expediting permits for this new facility, which made certain the team could keep construction on track to meet aggressive opening day schedules.”
For more than 25 years, VHB has partnered with local developers and the City of Waltham on major developments which have resulted in economic benefits to the community. In-depth knowledge of the city’s permitting and planning process, and relationships with local agencies, has been instrumental in moving projects forward. VHB developed the infrastructure to support Wolverine’s and Thermo Fisher Scientific’s new headquarters in Waltham and partnered with MassDOT and BXP on the design of new operational and safety improvement modifications to a major interchange off of Route 128 that feeds this site. VHB has also been instrumental in assisting with the repositioning of 1265 Main Street, former home of Polaroid, which will deliver more than 1.5 million square feet of commercial space for the city.